INSTITUT FÜR BIOMETRIE UND MEDIZINISCHE INFORMATIK

Publikationen

Artikel

  • J. Warneke, Z. Wang, M. Zeller, D. Leibfritz, M. Plaumann, V.A. Azov

Methacryloyl chloride dimers: from structure elucidation to a manifold of chemical transformations, Tetrahedron, 2014, 70, 6515-6521.

DOI: 10.1016/j.tet.2014.07.019.

  • J. Warneke, M. Plaumann, Z. Wang, E. Böhler, D. Kemken, S. Kelm, D. Leibfritz, V.A. Azov

New Insights into the Old Reaction between Pyridine and Acryloyl Chloride, Tetrahedron Letters, 2015, 56, 1124–1127.

DOI: 10.1016/j.tetlet.2015.01.100.

  • J. Warneke, C. Jenne, J. Bernarding, V. A. Azov, M. Plaumann

Evidence for an intrinsic binding force between dodecaborate dianions and receptors with hydrophobic binding pockets, Chem. Commun., 2016, 52, 6300-6303.

DOI: 10.1039/C6CC01233G.

  • J. Backenköhler, B. Reck, M. Plaumann, P. Spiteller

Total Synthesis of Mycenarubin A, Sanguinolentaquinone and Mycenaflavin B and their Cytotoxic Activities, Eur. J. Org. Chem., 2018, 22, 2806–2816.

DOI: 10.1002/ejoc.201800417.

  • H. Schrey, J. Backenköhler, H. Kogler, M. Plaumann, P. Spiteller

Aminotenuazonic Acid – Isolation, Structure Elucidation, Total Synthesis and Herbicidal Activity of a New Tetramic Acid from Fruiting Bodies of Laccaria Species, Chem. Eur. J., 2019, 25(44), 10333-10341.

DOI: 10.1002/chem.201901405.

Konferenzbeiträge

  • T. Dansauer, M. Plaumann, D. Kemken, E. Küstermann, D. Leibfritz

Fluorinated Gd-DTPA-Contrast Agents for 19F-Molecular MR Imaging

SMI 2005, # 367, Köln (Deutschland)

  • M. Plaumann, J. Willmann, T. Dansauer, D. Leibfritz

Synthesis, characterisation and comparison of 3,5-bistrifluoromethyl substituted phenyl Gd-DTPA- and Gd-DOTA- complexes for 19F-molecular imaging

ISFC 2006, # ORG_101, Bremen (Deutschland)

  • M. Plaumann, J. Willmann, T. Dansauer, E. Küstermann, D. Leibfritz

Synthesis and comparison of fluorinated Gd-DTPA- and Gd-DOTA-Contrast agents for 19F-molecular imaging

ESMRMB 2006, # 535, Warschau (Polen)

  • M. Plaumann, J. Willmann, D. Leibfritz

Charakterisierung Gd3+-haltiger Kontrastmittel mittels HPLC-ESI-MS

DGMS 2007, # 22, Bremen (Deutschland)

  • M. Plaumann, J. Willmann, D. Leibfritz

Synthesis and characterisation of fluorinated acyclic and macrocyclic Gd3+-complexes

SMI 2007, # 937, Providence (USA)

  • M. Plaumann, J. Willmann, D. Leibfritz

Estimation of lipophilicity of complexes with different lanthanide(III) ions

SMI 2007, # 938, Providence (USA)

  • M. Plaumann, J. Willmann, D. Leibfritz

Untersuchung lipophiler Eigenschaften von M3+-Kontrastmitteln mittels HPLC-ESI-MS

DGMS 2008, POr69, Gießen (Deutschland)

  • M. Plaumann, J. Willmann, E. Küstermann, Uwe Schüssler, D. Leibfritz

Rat glioma C6 cells labeled with a fluorinated Gd-GlyMe-DOTA-complex

Proc. Intl. Soc. Mag. Reson. Med. 2008, 16, 1693

  • M. Plaumann, J. Willmann, D. Leibfritz

Influence of temperature, pH, metalion and ligand system of the 19F-chemical shifts of fluorinated contrast agents

ESMRMB 2008, #587, Valencia (Spanien)

  • M. Plaumann, E. Küstermann, D. Leibfritz

New fluorinated Gd-AspGlyMe-DOTA complexes for 19F-MRI

Proc. Intl. Soc. Mag. Reson. Med. 2009, 17, 899

  • M. Plaumann, J. Willmann, D. Leibfritz

Observation of H/D-exchanges using ESI-MS

IMSC 2009, # 222, Bremen (Deutschland)

  • M. Plaumann, M. Bipoun, D. Leibfritz

Comparison of different fluorinated AspGlyMe-DOTA- and GluGlyMe-DOTA-Gd-complexes

WMIC 2009, # 619, Montreal (Kanada)

  • M. Plaumann, D. Leibfritz

Synthesis of an isotope labelled Gd-complex

WMIC 2009, # 620, Montreal (Kanada)

  • M. Plaumann, Y. Neumann, D. Leibfritz

Novel lipophilic fluorinated TPP-Gd-contrast agents

ESMRMB 2009, # 464, Antalya (Türkei)

  • M. Plaumann, D. Leibfritz

Fluorinated contrast agents with cation depending T1 sensitivity

Joint Meeting of ISMRM and ESMRMB 2010, # 4225, Stockholm (Schweden)

  • M. Plaumann, E. Küstermann, D. Leibfritz

Bis(Gd3+-GlyMe-DOTA)-Contrast Agent for 19F-Molecular MR Imaging at 7T

WMIC 2010, #P0937B, Kyoto (Japan)

  • M. Plaumann, D. Kemken, T. Dülcks, D. Leibfritz

 Untersuchung der Fragmentierungen von auf Cyclen basierenden Ligandensystemen mittels ESI-MS/MS und MS³

DGMS 2015, Wuppertal (Deutschland), PII17

  • J. Warneke,V.A. Azov, J. Bernarding, C. Jenne, M. Plaumann

Chemical masked dianion [B12F12]2- enabled cell labeling

ESMRMB 2015, #46, Edinburgh (Schottland, UK)

  • V.A. Azov, J. Warneke, M. Plaumann

Gas-phase binding study of dodecaborate dianions and receptors with hydrophobic binding pockets

Symposium on Cooperative Effects in Chemistry, 2016, Collaborative Research Center, SFB 858, Münster (Deutschland)

  • C. Bruns, T. Herrmann, C.-H. Oh, S. Kumar, M. Plaumann, C. Lee, J. Bernarding

Transmit-/Receive System for Hi-res Micro Imaging with 19F Contrast Agent at 7 T UHF MRI

ESMRMB 2016, #News 9, Wien (Österreich)

  • C. Bruns, T. Herrmann, M. Plaumann, C.-H. Oh, C. Lee, S. Kumar, J. Bernarding

Unified Proton and Fluorine Imaging of Small and Low Spin Density Samples at a Human Whole-Body 7T MRI

Proc. Intl. Soc. Mag. Reson. Med. 2017, 4405, Honolulu (USA)

  • J. Backenköhler, B. Reck, M. Plaumann, P. Spiteller

Total Synthesis of Mycenaflavin B and Mycenarubin A

ESOC 2017, SY133, Köln (Deutschland)

  • F. Euchner, C. Bruns, R. Ringleb, D. Müller, U. Bommerich, T. Herrmann, M. Plaumann, J. Bernarding

Construction of an MRI flow-phantom based on MR imaging data of a rats head

EMIM, 2018, #268, San Sebastián (Spanien)

  • M. Plaumann

 19F MR spectroscopy and -imaging - prospects in neuroscience

Seminar "Bildgebende Verfahren in den Neurowissenschaften", 2019, Universitätsklinikum Jena (Deutschland)

  • M. Plaumann

19F-MR-Analytik und -Bildgebung für die medizinische Diagnostik

Studentische Tagung in der Chemie, 2019, Universität Bremen (Deutschland)

  • M. Plaumann, J. Bernarding

NMR study of the acid-promoted hydrolysis of 2-fluoropyridine derivatives

21st ISMAR-15th EUROMAR Jount Conference, 2019, #370, Berlin (Deutschland)

Letzte Änderung: 23.08.2022 - Ansprechpartner:

Sie können eine Nachricht versenden an: Webmaster
Sicherheitsabfrage:
Captcha
 
Lösung: